Johnson & Johnson is looking to sell its Cerenovus stroke therapy business, according three unnamed people "with knowledge of ...
23h
The global joint replacement devices market, valued at US$22.50 billion in 2023, is forecasted to grow at a robust CAGR of 4.8%, reaching US$23.42 ...
The global joint replacement devices market, valued at US$22.50 billion in 2023, is forecasted to grow at a robust CAGR of 4.8%, reaching US$23.42 billion in 2024 and an impressive US$31.09 billion by ...
Johnson & Johnson MedTech (NYSE: JNJ) announced today that it launched the CereGlide 92 catheter system for treating acute ...
We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback